Home › Small Cell Lung Cancer
Pag-aaral pangklinika para sa Small Cell Lung Cancer na nagre-recruit sa U.S.
98 pag-aaral para sa Small Cell Lung Cancer ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX26 pag-aaral
- Arlington, VA23 pag-aaral
- Boston, MA21 pag-aaral
- New York City, NY21 pag-aaral
- Nashville, TN20 pag-aaral
- Los Angeles, CA20 pag-aaral
- Orlando, FL15 pag-aaral
- Dallas, TX13 pag-aaral
- St. Louis, MO13 pag-aaral
- Cleveland, OH13 pag-aaral
- Detroit, MI12 pag-aaral
- Chicago, IL12 pag-aaral
- Washington, DC12 pag-aaral
- Baltimore, MD11 pag-aaral
- San Antonio, TX11 pag-aaral
- Philadelphia, PA10 pag-aaral
- Seattle, WA10 pag-aaral
- Atlanta, GA9 pag-aaral
- Durham, NC9 pag-aaral
- Grand Rapids, MI9 pag-aaral
- Tampa, FL9 pag-aaral
- Edison, NJ9 pag-aaral
- Queens, NY9 pag-aaral
- Indianapolis, IN9 pag-aaral
- Akron, OH8 pag-aaral
- Aurora, CO8 pag-aaral
- Columbus, OH8 pag-aaral
- Cedar Rapids, IA8 pag-aaral
- Miami, FL8 pag-aaral
- Omaha, NE8 pag-aaral
- Portland, OR8 pag-aaral
- Austin, TX7 pag-aaral
- New Haven, CT7 pag-aaral
- Louisville, KY7 pag-aaral
- Lexington, KY7 pag-aaral
- Cincinnati, OH7 pag-aaral
- West Valley City, UT7 pag-aaral
- Clifton, NJ6 pag-aaral
- Denver, CO6 pag-aaral
- Irving, TX6 pag-aaral
Ayos sa estado
- Alabama10 pag-aaral
- Arizona9 pag-aaral
- Arkansas5 pag-aaral
- California36 pag-aaral
- Colorado16 pag-aaral
- Connecticut9 pag-aaral
- District of Columbia5 pag-aaral
- Florida36 pag-aaral
- Georgia12 pag-aaral
- Illinois21 pag-aaral
- Indiana12 pag-aaral
- Iowa8 pag-aaral
- Kansas3 pag-aaral
- Kentucky15 pag-aaral
- Maryland19 pag-aaral
- Massachusetts22 pag-aaral
- Michigan26 pag-aaral
- Minnesota9 pag-aaral
- Missouri17 pag-aaral
- Nebraska10 pag-aaral
- New Jersey17 pag-aaral
- New Mexico3 pag-aaral
- New York31 pag-aaral
- North Carolina16 pag-aaral
- Ohio28 pag-aaral
- Oklahoma4 pag-aaral
- Oregon9 pag-aaral
- Pennsylvania15 pag-aaral
- South Carolina7 pag-aaral
- South Dakota3 pag-aaral
- Tennessee24 pag-aaral
- Texas41 pag-aaral
- Utah11 pag-aaral
- Virginia30 pag-aaral
- Washington13 pag-aaral
- Wisconsin11 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07155174Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT02146170Prospective Multiomic Analysis in Small-Cell Lung Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07795411Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07509034The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03460977A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07472517Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07476287Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07226999A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07099898DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07006727Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07488676A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06066138Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432Study of Trilaciclib and Lurbinectidin
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05578326A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07730021A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07459634A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07407933Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.